Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F20%3A00535227" target="_blank" >RIV/61388971:_____/20:00535227 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61989592:15110/20:73605109
Výsledek na webu
<a href="https://www.frontiersin.org/articles/10.3389/fphar.2020.01303/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fphar.2020.01303/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fphar.2020.01303" target="_blank" >10.3389/fphar.2020.01303</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences
Popis výsledku v původním jazyce
Sexual differences and the composition/function of the gut microbiome are not considered the most important players in the drug metabolism field, however, from the recent data it is obvious that they may significantly affect the response of the patient to therapy. Here, we evaluated the effect of microbial colonization and sex differences on mRNA expression and the enzymatic activity of hepatic cytochromes P450 (CYPs) in germ-free (GF) mice, lacking the intestinal flora, and control specific-pathogen-free (SPF) mice. We observed a significant increase in the expression ofCyp3a11in female SPF mice compared to the male group. However, the sex differences were erased in GF mice, and the expression ofCyp3a11was about the same in both sexes. We have also found higherCyp2c38gene expression in female mice compared to male mice in both the SPF and GF groups. Moreover, these changes were confirmed at the level of enzymatic activity, where the female mice exhibit higher levels of functional CYP2C than males in both groups. Interestingly, we observed the same trend as with CYP3A enzymes: a diminished difference between the sexes in GF mice. The presented data indicate that the mouse gut microbiome plays an important role in sustaining sexual dimorphism in terms of hepatic gene expression and metabolism.
Název v anglickém jazyce
Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences
Popis výsledku anglicky
Sexual differences and the composition/function of the gut microbiome are not considered the most important players in the drug metabolism field, however, from the recent data it is obvious that they may significantly affect the response of the patient to therapy. Here, we evaluated the effect of microbial colonization and sex differences on mRNA expression and the enzymatic activity of hepatic cytochromes P450 (CYPs) in germ-free (GF) mice, lacking the intestinal flora, and control specific-pathogen-free (SPF) mice. We observed a significant increase in the expression ofCyp3a11in female SPF mice compared to the male group. However, the sex differences were erased in GF mice, and the expression ofCyp3a11was about the same in both sexes. We have also found higherCyp2c38gene expression in female mice compared to male mice in both the SPF and GF groups. Moreover, these changes were confirmed at the level of enzymatic activity, where the female mice exhibit higher levels of functional CYP2C than males in both groups. Interestingly, we observed the same trend as with CYP3A enzymes: a diminished difference between the sexes in GF mice. The presented data indicate that the mouse gut microbiome plays an important role in sustaining sexual dimorphism in terms of hepatic gene expression and metabolism.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30102 - Immunology
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Frontiers in Pharmacology
ISSN
1663-9812
e-ISSN
—
Svazek periodika
11
Číslo periodika v rámci svazku
OCT 2 2020
Stát vydavatele periodika
CH - Švýcarská konfederace
Počet stran výsledku
6
Strana od-do
01303
Kód UT WoS článku
000577726800001
EID výsledku v databázi Scopus
2-s2.0-85092776545